Forvis Mazars Wealth Advisors LLC Has $2.37 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Forvis Mazars Wealth Advisors LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 2.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,325 shares of the conglomerate’s stock after selling 269 shares during the period. Forvis Mazars Wealth Advisors LLC’s holdings in Danaher were worth $2,370,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of DHR. Kentucky Retirement Systems Insurance Trust Fund boosted its position in shares of Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after buying an additional 2,202 shares during the period. Fort Pitt Capital Group LLC grew its position in Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after purchasing an additional 7,421 shares in the last quarter. ORG Partners LLC increased its stake in Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after buying an additional 2,559 shares during the last quarter. Harvest Portfolios Group Inc. lifted its position in Danaher by 1.2% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after buying an additional 2,465 shares in the last quarter. Finally, Generate Investment Management Ltd acquired a new position in shares of Danaher during the 4th quarter worth about $8,044,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. Jefferies Financial Group lowered their target price on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a report on Thursday, October 31st. Barclays cut their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Trading Up 0.9 %

DHR stock opened at $209.86 on Monday. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company has a market capitalization of $151.58 billion, a PE ratio of 39.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The company’s 50-day simple moving average is $226.71 and its 200 day simple moving average is $246.84. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm posted $2.09 EPS. As a group, sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.61%. Danaher’s payout ratio is currently 20.45%.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.